Where does Palo Alto Investors LP rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Palo Alto Investors LP ranks #10,720 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Palo Alto Investors LP hold?

Palo Alto Investors LP holds 29 US utility patents granted between 2016 and 2024, spanning 16 technology areas.

What is Palo Alto Investors LP's Innovation Score?

Palo Alto Investors LP has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Palo Alto Investors LP focus on?

Palo Alto Investors LP's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 19 patents, ranking #1,197 of 7,163 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is Palo Alto Investors LP's patent grant rate increasing or decreasing?

Palo Alto Investors LP's recent grant velocity is +42% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Palo Alto Investors LP's patents?

Palo Alto Investors LP's patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Palo Alto Investors LP patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Palo Alto Investors LP

USPTO PatentsView assignee record - 29 granted patents across 16 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Palo ranks #10,720 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 16 technology areas.

#10,720
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 15.6
avg claims per patent: +42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10720 · US Corporation #10,720 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,720/49,997
PHOTO-FINISH Pegavision
CPC-FOCUS A61K · 16 areas
INNOV-THIN 38.8/100
CLAIMS-RICH 15.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +42% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pegavision Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Palo’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (30%) Velocity 3.6 pts (9%) Breadth 14.1 pts (36%) Claim depth 9.3 pts (24%)

Qualcomm Incorporated · highest

85
Fondazione Telethon · near

39
Numenta · near

39
Palo Alto Investors · this assignee

39
SetPoint Medical · near

39
The Board of… · near

39
3D Lighting… · lowest

7

What this shows Palo's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Palo?

Each dot is one of Palo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Palo’s own 15.6 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Palo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Palo's grants concentrate

Palo Alto Investors LP is a focused PatentsView assignee: 16 CPC subclasses with 65.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2023. By volume, Palo sits between Pegavision Corporation and Quark Pharmaceuticals, Inc..

Palo's three-year grant acceleration

Palo Alto Investors LP shows 7 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pegavision

29
Powdermet

29
Probiotical S P A

29
Protalus

29
Phazr

29
Prüftechnik Diete…

29
Qingdao Haier AIR…

29
Quark Pharmaceuti…

29
Palo Alto Investo… ◀

29

What this shows Palo holds 29 patents at rank #10,726, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Palo

By rank, the assignees closest to #10,726 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Palo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Palo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Palo ranks #1,197 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Numenta, Inc. 39 SetPoint Medical Corporation 39 The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada 39 Fondazione Telethon 39

Palo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Palo Alto Investors LP patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	10.3%
2017	4	13.8%
2018	2	6.9%
2019	3	10.3%
2020	4	13.8%
2021	6	20.7%
2022	5	17.2%
2023	1	3.4%
2024	1	3.4%

Which technologies does Palo Alto Investors LP patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 17

A61B - DIAGNOSIS; SURGERY; Identification 10

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07K - Peptides 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Palo Alto Investors LP's patent record in context - here's where to go next.

Palo Alto Investors LP's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 65.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #10,720 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Palo Alto Investors LP against Pegavision Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.